Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 3
2008 4
2009 11
2010 11
2011 8
2012 6
2013 8
2014 4
2015 12
2016 17
2017 5
2018 8
2019 7
2020 7
2021 13
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Anaplastic large-cell lymphoma.
Inghirami G, Pileri SA; European T-Cell Lymphoma Study Group. Inghirami G, et al. Semin Diagn Pathol. 2011 Aug;28(3):190-201. doi: 10.1053/j.semdp.2011.03.002. Semin Diagn Pathol. 2011. PMID: 21850985 Review.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Sacco A, Desantis V, Celay J, Giustini V, Rigali F, Savino FD, Cea M, Soncini D, Cagnetta A, Solimando AG, D'Aliberti D, Spinelli S, Ramazzotti D, Almici C, Todoerti K, Neri A, Anastasia A, Tucci A, Motta M, Chiarini M, Kawano Y, Martinez-Climent JA, Piazza R, Roccaro AM. Sacco A, et al. Among authors: todoerti k. Blood. 2023 May 25;141(21):2615-2628. doi: 10.1182/blood.2022019240. Blood. 2023. PMID: 36735903
Bioinformatics Pipeline to Analyze lncRNA Arrays.
Todoerti K, Ronchetti D, Manzoni M, Taiana E, Neri A, Agnelli L. Todoerti K, et al. Methods Mol Biol. 2021;2348:45-53. doi: 10.1007/978-1-0716-1581-2_3. Methods Mol Biol. 2021. PMID: 34160798
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.
Morelli E, Fulciniti M, Samur MK, Ribeiro CF, Wert-Lamas L, Henninger JE, Gullà A, Aktas-Samur A, Todoerti K, Talluri S, Park WD, Federico C, Scionti F, Amodio N, Bianchi G, Johnstone M, Liu N, Gramegna D, Maisano D, Russo NA, Lin C, Tai YT, Neri A, Chauhan D, Hideshima T, Shammas MA, Tassone P, Gryaznov S, Young RA, Anderson KC, Novina CD, Loda M, Munshi NC. Morelli E, et al. Among authors: todoerti k. Blood. 2023 Jan 26;141(4):391-405. doi: 10.1182/blood.2022016892. Blood. 2023. PMID: 36126301 Free PMC article.
Anaplastic lymphoma kinase in human cancer.
Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni M, Kwee I, Bertoni F, Piccaluga PP, Pileri SA, Inghirami G; European T-Cell Lymphoma Study Group. Barreca A, et al. J Mol Endocrinol. 2011 Jul 4;47(1):R11-23. doi: 10.1530/JME-11-0004. Print 2011 Aug. J Mol Endocrinol. 2011. PMID: 21502284 Review.
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma.
Gelli E, Soncini D, Becherini P, Martinuzzi C, Todoerti K, Cagnetta A, Aquino S, Guolo F, Miglino M, Bruzzone S, Nencioni A, Neri A, Lemoli RM, Cea M. Gelli E, et al. Among authors: todoerti k. Blood Adv. 2023 Jul 25;7(14):3472-3478. doi: 10.1182/bloodadvances.2022009035. Blood Adv. 2023. PMID: 36897214 Free PMC article. No abstract available.
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents.
Becherini P, Soncini D, Ravera S, Gelli E, Martinuzzi C, Giorgetti G, Cagnetta A, Guolo F, Ivaldi F, Miglino M, Aquino S, Todoerti K, Neri A, Benzi A, Passalacqua M, Nencioni A, Perrotta I, Gallo Cantafio ME, Amodio N, De Flora A, Bruzzone S, Lemoli RM, Cea M. Becherini P, et al. Among authors: todoerti k. Antioxidants (Basel). 2023 Feb 15;12(2):494. doi: 10.3390/antiox12020494. Antioxidants (Basel). 2023. PMID: 36830052 Free PMC article.
Primary Plasma Cell Leukemia: Identity Card 2016.
Musto P, Simeon V, Todoerti K, Neri A. Musto P, et al. Among authors: todoerti k. Curr Treat Options Oncol. 2016 Apr;17(4):19. doi: 10.1007/s11864-016-0392-6. Curr Treat Options Oncol. 2016. PMID: 26995215 Review.
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.
Morabito F, Tripepi G, Martino EA, Vigna E, Mendicino F, Morabito L, Todoerti K, Al-Janazreh H, D'Arrigo G, Canale FA, Cutrona G, Neri A, Martino M, Gentile M. Morabito F, et al. Among authors: todoerti k. Drug Des Devel Ther. 2021 Jul 8;15:2969-2978. doi: 10.2147/DDDT.S295215. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34262262 Free PMC article. Review.
Primary plasma cell leukemia 2.0: advances in biology and clinical management.
Neri A, Todoerti K, Lionetti M, Simeon V, Barbieri M, Nozza F, Vona G, Pompa A, Baldini L, Musto P. Neri A, et al. Among authors: todoerti k. Expert Rev Hematol. 2016 Nov;9(11):1063-1073. doi: 10.1080/17474086.2016.1244002. Epub 2016 Oct 24. Expert Rev Hematol. 2016. PMID: 27759436 Review.
119 results